Search research articles
Contact Us
Filters
Showing results (161-170 of 171) with videos related to
Page
of 18
Sort By:
Journal of Molecular Medicine (Berlin, Germany)
|
March 31, 2017
Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options
Romy Strauß, Thomas Rose, Shaun M Flint, et al.
Kidney International
|
June 28, 2020
Nuclear antigen-reactive CD4<sup>+</sup> T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys
Dimas Abdirama, Sebastian Tesch, Anna-Sophie Grießbach, et al.
RMD Open
|
January 4, 2023
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, et al.
Annals of the Rheumatic Diseases
|
February 25, 2025
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
Elise Siegert, Robert Biesen, Maria Dzamukova, et al.
Clinical and Experimental Rheumatology
|
November 30, 2020
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
Gerd-Rüdiger Burmester, José María Álvaro-Gracia, Neil Betteridge, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety
Frank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
The Journal of Rheumatology
|
September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)
Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
International Journal of Rheumatic Diseases
|
May 9, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges
Mrudula Joshi, Naitica Darooka, Sreoshy Saha, et al.
Rheumatology International
|
October 14, 2024
Correction to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies
Esha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Rheumatology International
|
April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
Esha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 171) with videos related to
Sort By:
Page
of 18
Journal of Molecular Medicine (Berlin, Germany)
|
March 31, 2017
Type I interferon as a biomarker in autoimmunity and viral infection: a leukocyte subset-specific analysis unveils hidden diagnostic options
Romy Strauß, Thomas Rose, Shaun M Flint, et al.
Kidney International
|
June 28, 2020
Nuclear antigen-reactive CD4<sup>+</sup> T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys
Dimas Abdirama, Sebastian Tesch, Anna-Sophie Grießbach, et al.
RMD Open
|
January 4, 2023
Type of vaccine and immunosuppressive therapy but not diagnosis critically influence antibody response after COVID-19 vaccination in patients with rheumatic disease
Leonie Maria Frommert, Amanthi Nadira Arumahandi de Silva, Jan Zernicke, et al.
Annals of the Rheumatic Diseases
|
February 25, 2025
Teclistamab in relapsed systemic sclerosis after autologous haematopoietic stem cell transplantation
Elise Siegert, Robert Biesen, Maria Dzamukova, et al.
Clinical and Experimental Rheumatology
|
November 30, 2020
Evolving the comprehensive management of rheumatoid arthritis: identification of unmet needs and development of practical and educational tools
Gerd-Rüdiger Burmester, José María Álvaro-Gracia, Neil Betteridge, et al.
Clinical and Experimental Rheumatology
|
April 7, 2016
Clinical experience with the European Ankylosing Spondylitis Infliximab Cohort (EASIC): long-term extension over 7 years with focus on clinical efficacy and safety
Frank Heldmann, Xenofon Baraliakos, Uta Kiltz, et al.
The Journal of Rheumatology
|
September 18, 2012
Efficacy and safety of rituximab treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitides: results from a German registry (GRAID)
Petra Roll, Eva Ostermeier, Marion Haubitz, et al.
International Journal of Rheumatic Diseases
|
May 9, 2024
Listening to patients, for the patients: The COVAD Study-Vision, organizational structure, and challenges
Mrudula Joshi, Naitica Darooka, Sreoshy Saha, et al.
Rheumatology International
|
October 14, 2024
Correction to: Collating the voice of people with autoimmune diseases: Methodology for the third phase of the COVAD studies
Esha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Rheumatology International
|
April 12, 2024
Collating the voice of people with autoimmune diseases: Methodology for the Third Phase of the COVAD Studies
Esha Kadam, Mahnoor Javaid, Parikshit Sen, et al.
Page
of 18